Stay updated on BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial
Sign up to get notified when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.

Latest updates to the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.3.3 to v3.3.4, and no substantive study details, eligibility criteria, or contacts were changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a new Locations section listing Colorado, Georgia, Illinois, Massachusetts, New York, South Carolina, and Texas, and removed the state-specific location blocks and the HHS Vulnerability Disclosure link. The revision tag updated to v3.3.3.SummaryDifference0.9%

- Check51 days agoChange DetectedThe revision line now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the government funding lapse disclaimer from the page. The disclaimer previously warned that information may not be up to date due to funding gaps.SummaryDifference0.4%

- Check73 days agoChange DetectedThe two screenshots show the same study record with minor UI/formatting adjustments; core study content such as arms, eligibility criteria, and outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check102 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference4%

Stay in the know with updates to BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI608 Combo with Immune Checkpoint Inhibitors Clinical Trial page.